ProQR Therapeutics N.V. (PRQR)

ProQR Therapeutics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	132.41	149.41	118.93	94.78	187.52	75.84
Cash & Short-Term Investments	132.41	149.41	118.93	94.78	187.52	75.84
Cash Growth	28.92%	25.63%	25.48%	-49.46%	147.27%	-32.26%
Accounts Receivable	-	-	-	56.25	-	-
Other Receivables	0.53	2.03	1.27	0.98	0.82	0.8
Receivables	0.53	2.03	1.27	57.24	0.82	0.8
Prepaid Expenses	5.14	2.41	0.79	2.45	3.14	3.38
Total Current Assets	138.08	153.85	120.99	154.46	191.48	80.02
Property, Plant & Equipment	13.61	14.11	16.9	16.24	17.47	18.6
Long-Term Investments	-	-	-	0.62	0.63	0.11
Total Assets	151.69	167.96	137.88	171.32	209.58	98.73
Accounts Payable	0.41	0.02	1.54	0.39	0.19	0.22
Accrued Expenses	0.48	1.48	1.66	1.12	1.23	6.15
Current Portion of Long-Term Debt	4.66	4.58	-	2.5	4.77	1.14
Current Portion of Leases	1.46	1.57	1.61	1.39	1.53	1.26
Current Unearned Revenue	19.25	21.94	20.57	5.64	5.12	0.7
Other Current Liabilities	7.46	9.32	8.82	9.95	14.76	0.84
Total Current Liabilities	33.72	38.9	34.2	20.99	27.6	10.3
Long-Term Debt	-	-	4.29	4.27	39.32	16.19
Long-Term Leases	10.74	11.07	13.83	13.81	14.75	15.69
Long-Term Unearned Revenue	28.3	29.43	44.17	65.57	14.69	-
Total Liabilities	72.75	79.4	96.49	104.64	96.35	42.18
Common Stock	78.94	4.31	3.37	3.37	3	2.17
Additional Paid-In Capital	-	483.81	412.89	412.54	398.31	288.76
Retained Earnings	-	-427.16	-400.85	-379.11	-317.77	-257.75
Comprehensive Income & Other	-	27.6	25.98	30.26	30.3	23.92
Total Common Equity	78.94	88.56	41.39	67.07	113.83	57.09
Minority Interest	-	-	-	-0.38	-0.6	-0.55
Shareholders' Equity	78.94	88.56	41.39	66.68	113.23	56.55
Total Liabilities & Equity	151.69	167.96	137.88	171.32	209.58	98.73
Total Debt	16.85	17.22	19.73	21.97	60.37	34.28
Net Cash (Debt)	115.56	132.19	99.19	72.8	127.15	41.56
Net Cash Growth	38.42%	33.27%	36.24%	-42.74%	205.94%	-57.76%
Net Cash Per Share	1.26	1.54	1.22	1.02	1.98	0.83
Filing Date Shares Outstanding	105.3	105.21	81.35	80.82	71.29	50.2
Total Common Shares Outstanding	105.3	105.21	81.35	80.82	71.29	50.2
Working Capital	104.36	114.94	86.78	133.47	163.89	69.72
Book Value Per Share	0.75	0.84	0.51	0.83	1.60	1.14
Tangible Book Value	78.94	88.56	41.39	67.07	113.83	57.09
Tangible Book Value Per Share	0.75	0.84	0.51	0.83	1.60	1.14
Buildings	-	23.79	24.78	22.86	22.23	21.64
Machinery	-	6.82	5.91	4.91	4.25	3.63

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q